Literature DB >> 151100

Enzymatically active Ca2+ ATPase from sarcoplasmic reticulum membranes, solubilized by nonionic detergents. Role of lipid for aggregation of the protein.

M L Maire, K E Lind, K E Jørgensen, H Røigaard, J V Møller.   

Abstract

The present study provides data on the properties of Ca2+-dependent Atpase of sarcoplasmic reticulum in states intermediary between the fully detergent-solubilized and vesicular form. After solubilization of ATPase vesicles by dodecyloctaoxyethylene glycol monoether (C12E8), the protein is mainly present as a monomer exhibiting enzymatic activity. Gel chromatography in presence or absence of Tween 80 gives rise to formation of oligomers of various size and smaller amounts of monomeric ATPase. Only the oligomeric species retain enzymatic activity (half-life, 3 to 4 days), while the gel chromatographic monomer is enzymatically inactive. Teteramers or trimers of ATPase, containing approximately 22 mol of phospholipid/mol of ATPase, are the smallest enzymatically active units after gel chromatography. Formation of larger sized particles and vesicles of ATPase appears to depend on the presence of sufficient lipid to make a cohesion between the tetrameric or trimeric units. The protein appears to be partially deaggregated by a relatively high Tween 80 concentration in the eluant (0.5 mg/ml) and under these conditions, phospholipid binding is reduced to a low level (approximately 11 mol/mol of protein). The data indicate that any bonds between ATPase polypeptide chains are easily disrupted by detergent and that lipid also may play a role in mediating contact between individual polypeptide chains in the tetrameric or trimeric units. Phospholipid analysis and exchange experiments indicate that the phospholipid left on ATPase after solubilization has a similar composition to that of the whole membrane. The binding of Tween 80 by soluble ATPase above the critical micellar concentration is 0.23 to 0.29 g/g of protein. The inactive monomer of ATPase binds phospholipid and Tween 80 to about the same extent, but has a slightly different circular dichroism spectrum, than oligomeric ATPase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 151100

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae.

Authors:  Marie Jidenko; Rikke C Nielsen; Thomas Lykke-Møller Sørensen; Jesper V Møller; Marc le Maire; Poul Nissen; Christine Jaxel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

2.  Intermolecular interactions in the mechanism of skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase (SERCA1): evidence for a triprotomer.

Authors:  James E Mahaney; David D Thomas; Iain K Farrance; Jeffrey P Froehlich
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

3.  Active detergent-solubilized H+,K+-ATPase is a monomer.

Authors:  Ingrid Dach; Claus Olesen; Luca Signor; Poul Nissen; Marc le Maire; Jesper V Møller; Christine Ebel
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

4.  A liquid diffraction analysis of sarcoplasmic reticulum. I. Compositional variation.

Authors:  G W Brady; D B Fein; M E Harder; R Spehr; G Meissner
Journal:  Biophys J       Date:  1981-04       Impact factor: 4.033

Review 5.  The sarcoplasmic reticulum Ca2+-ATPase.

Authors:  J V Møller; J P Andersen; M le Maire
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

6.  Inactivation of sarcoplasmic-reticulum Ca(2+)-ATPase in low-frequency-stimulated muscle results from a modification of the active site.

Authors:  S Matsushita; D Pette
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

7.  Optimisation of recombinant production of active human cardiac SERCA2a ATPase.

Authors:  Ana V Antaloae; Cédric Montigny; Marc le Maire; Kimberly A Watson; Thomas L-M Sørensen
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.